UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 18, 2023
TEXAS INSTRUMENTS INCORPORATED
(Exact name of registrant as specified in charter)
DELAWARE | 001-03761 | 75-0289970 | ||
(State or other jurisdiction of incorporation) | (Commission file number) | (I.R.S. employer identification no.) |
12500 TI BOULEVARD |
DALLAS, TEXAS75243 |
(Address of principal executive offices) |
Registrant's telephone number, including area code: (214)479-3773
Check the appropriate box below if the Form 8-Kis intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencementcommunications pursuant to Rule 14d-2(b)under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencementcommunications pursuant to Rule 13e-4(c)under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, par value $1.00 | TXN | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2of the Securities Exchange Act of 1934 (§240.12b-2of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. | Other Events |
Issuance of $1,600,000,000 of Notes
On May 18, 2023, Texas Instruments Incorporated ("Texas Instruments") consummated the issuance and sale of $200,000,000 aggregate principal amount of its 4.600% Notes due 2028 (the "2028 Notes"), $200,000,000 aggregate principal amount of its 4.900% Notes due 2033 (the "2033 Notes") and $1,200,000,000 aggregate principal amount of its 5.050% Notes due 2063 (the "2063 Notes" and, together with the 2028 Notes and the 2033 Notes, the "Notes"), pursuant to an underwriting agreement filed herewith as Exhibit 1.1 dated May 11, 2023 among Texas Instruments and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and U.S. Bancorp Investments, Inc., as underwriters. The Notes were issued pursuant to an Indenture dated as of May 23, 2011 (the "Indenture") between Texas Instruments and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee, and an Officers' Certificate issued pursuant thereto. The 2028 Notes and the 2033 Notes are a further issuance of, and form a single series with, the $500,000,000 aggregate principal amount of the existing 4.600% Notes due 2028 issued by Texas Instruments on November 18, 2022 and the $750,000,000 aggregate principal amount of the existing 4.900% Notes due 2033 issued by Texas Instruments on March 14, 2023, respectively. The 2063 Notes are a new issuance.
The Notes were offered pursuant to Texas Instruments' Registration Statement on Form S-3filed on February 4, 2022 (Reg. No. 333-262523),including the prospectus contained therein, and a related preliminary prospectus supplement dated May 11, 2023 and a prospectus supplement dated May 11, 2023.
The material terms and conditions of the Notes are set forth in the Indenture filed as Exhibit 4.2 to the Current Report of Texas Instruments on Form 8-Kdated May 23, 2011 and the Officers' Certificate filed herewith as Exhibit 4.1 and incorporated by reference herein.
Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits.
Exhibit | Description | |
1.1 | Underwriting Agreement dated May 11, 2023 among Texas Instruments Incorporated and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and U.S. Bancorp Investments, Inc. | |
4.1 | Officers' Certificate setting forth the terms of the Notes | |
5.1 | Opinion of Davis Polk & Wardwell LLP | |
23.1 | Consent of Davis Polk & Wardwell LLP (included in Exhibit 5.1) | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
TEXAS INSTRUMENTS INCORPORATED | |||||
Date: May 18, 2023 | By: | /s/ Rafael R. Lizardi | |||
Rafael R. Lizardi | |||||
Senior Vice President and Chief Financial Officer |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Texas Instruments Incorporated published this content on 18 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 May 2023 20:38:22 UTC.